Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biolidics Ltd. (SG:8YY)
SGX:8YY
Holding SG:8YY?
Track your performance easily
8YY Stock Chart & Stats
Day’s RangeS$0 - S$0
52-Week Range<S$0.01 - S$0.02
Previous CloseS$0.01
Volume5.70M
Average Volume (3M)2.29M
Market Cap
S$16.91M
Enterprise ValueS$17.20M
Total Cash (Recent Filing)S$3.96M
Total Debt (Recent Filing)S$4.25M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume2,534,030
30 Day Avg. Volume2,290,795
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biolidics Ltd. News
PremiumCompany Announcements
Biolidics Completes Acquisition to Expand E-Sports Presence
PremiumCompany Announcements
Biolidics Ltd. Approves Key Share Issuance and Transfer
PremiumCompany Announcements
Biolidics Ltd. Completes Major Share Issuance
PremiumCompany Announcements
Biolidics Ltd Announces New Share Listings
PremiumCompany Announcements
Biolidics Ltd Amends Subscription Agreement Terms
PremiumCompany Announcements
Biolidics Ltd Announces Major Acquisition and FundingPremiumCompany Announcements
Biolidics Ltd Announces Key Leadership ChangesPremiumCompany Announcements
Biolidics Limited Subsidiary Faces LiquidationOptions Prices
Currently, No data available
---
Ownership Overview
8YY FAQ
What was Biolidics Ltd.’s price range in the past 12 months?
Biolidics Ltd. lowest share price was <S$0.01 and its highest was S$0.02 in the past 12 months.
What is Biolidics Ltd.’s market cap?
Currently, no data Available
When is Biolidics Ltd.’s upcoming earnings report date?
Biolidics Ltd.’s upcoming earnings report date is Feb 26, 2025 which is in 95 days.
How were Biolidics Ltd.’s earnings last quarter?
Biolidics Ltd. released its earnings results on Nov 01, 2024. The company reported -S$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.001.
Is Biolidics Ltd. overvalued?
According to Wall Street analysts Biolidics Ltd.’s price is currently Overvalued.
Does Biolidics Ltd. pay dividends?
Biolidics Ltd. does not currently pay dividends.
What is Biolidics Ltd.’s EPS estimate?
Biolidics Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biolidics Ltd. have?
Biolidics Ltd. has 1,690,758,800 shares outstanding.
What happened to Biolidics Ltd.’s price movement after its last earnings report?
Biolidics Ltd. reported an EPS of -S$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biolidics Ltd.?
Currently, no hedge funds are holding shares in SG:8YY
---
Biolidics Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-23.07%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-80.51%
Trailing 12-Months
Company Description
Biolidics Ltd.
Biolidics Ltd is engaged in research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics related industrial design services and investment holding. Its segments include Cancer; Infectious diseases; Laboratory services; and Corporate segment. It derives major revenue from The infectious diseases segment that involves the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship network and direct customers in the infectious diseases field. Its operations are spread across Singapore, Japan, China, Europe, United States, Hong Kong, Philippines, Indonesia, and Others.
---
Technical Analysis
---